Crinetics Pharmaceuticals, Inc. (CRNX)
84.79
+0.10
(+0.12%)
USD |
NASDAQ |
Aug 24, 16:00
84.79
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Market Cap : 8.971B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 8.961B |
| August 20, 2026 | 8.961B |
| August 19, 2026 | 8.961B |
| August 18, 2026 | 8.964B |
| August 17, 2026 | 8.967B |
| August 14, 2026 | 8.962B |
| August 13, 2026 | 8.934B |
| August 12, 2026 | 8.937B |
| August 11, 2026 | 8.926B |
| August 10, 2026 | 8.904B |
| August 07, 2026 | 8.896B |
| August 06, 2026 | 8.879B |
| August 05, 2026 | 8.888B |
| August 04, 2026 | 8.873B |
| August 03, 2026 | 8.862B |
| July 31, 2026 | 8.837B |
| July 30, 2026 | 8.849B |
| July 29, 2026 | 8.834B |
| July 28, 2026 | 8.832B |
| July 27, 2026 | 8.831B |
| July 24, 2026 | 8.818B |
| July 23, 2026 | 8.810B |
| July 22, 2026 | 8.817B |
| July 21, 2026 | 8.836B |
| July 20, 2026 | 8.833B |
| Date | Value |
|---|---|
| July 17, 2026 | 8.832B |
| July 16, 2026 | 8.837B |
| July 15, 2026 | 8.836B |
| July 14, 2026 | 8.816B |
| July 13, 2026 | 8.812B |
| July 10, 2026 | 8.802B |
| July 09, 2026 | 8.806B |
| July 08, 2026 | 8.793B |
| July 07, 2026 | 8.797B |
| July 06, 2026 | 4.426B |
| July 02, 2026 | 4.447B |
| July 01, 2026 | 4.074B |
| June 30, 2026 | 3.941B |
| June 29, 2026 | 3.890B |
| June 26, 2026 | 3.865B |
| June 25, 2026 | 3.685B |
| June 24, 2026 | 3.810B |
| June 23, 2026 | 3.782B |
| June 22, 2026 | 3.726B |
| June 18, 2026 | 3.778B |
| June 17, 2026 | 3.765B |
| June 16, 2026 | 3.686B |
| June 15, 2026 | 3.699B |
| June 12, 2026 | 3.630B |
| June 11, 2026 | 3.531B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 138.77B |
| Johnson & Johnson | 657.57B |
| Eli Lilly & Co. | 1.175T |
| Pfizer Inc. | 159.46B |
| Bristol Myers Squibb Co. | 137.51B |
Market Cap Related Metrics
| PS Ratio | 200.62 |
| PEG Ratio | -0.7410 |
| Price to Book Value | 7.527 |
| Price | 84.79 |
| Earnings Yield | -5.95% |
| PEGY Ratio | -0.7410 |